ATA224578A - Verfahren zur herstellung eines neuen antibiotikums und seiner derivate - Google Patents

Verfahren zur herstellung eines neuen antibiotikums und seiner derivate

Info

Publication number
ATA224578A
ATA224578A AT224578A AT224578A ATA224578A AT A224578 A ATA224578 A AT A224578A AT 224578 A AT224578 A AT 224578A AT 224578 A AT224578 A AT 224578A AT A224578 A ATA224578 A AT A224578A
Authority
AT
Austria
Prior art keywords
derivatives
producing
new antibiotic
antibiotic
new
Prior art date
Application number
AT224578A
Other languages
English (en)
Other versions
AT362059B (de
Original Assignee
Sanraku Ocean Co
Panlabs Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP52035375A external-priority patent/JPS604719B2/ja
Priority claimed from JP9465177A external-priority patent/JPS5430195A/ja
Application filed by Sanraku Ocean Co, Panlabs Inc filed Critical Sanraku Ocean Co
Priority to AT18980A priority Critical patent/AT362506B/de
Publication of ATA224578A publication Critical patent/ATA224578A/de
Application granted granted Critical
Publication of AT362059B publication Critical patent/AT362059B/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Cephalosporin Compounds (AREA)
AT224578A 1977-03-31 1978-03-30 Verfahren zur herstellung eines neuen antibiotikums und seiner derivate AT362059B (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AT18980A AT362506B (de) 1977-03-31 1980-01-15 Verfahren zur herstellung von neuen ester- derivaten eines antibiotikums

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP52035375A JPS604719B2 (ja) 1977-03-31 1977-03-31 β‐ラクタマーゼ阻害活性を有する抗生物質ＰＳ―５の製造方法
JP9465177A JPS5430195A (en) 1977-08-09 1977-08-09 Antibiotic substance ps-5 having beta-lactamase inhibiting activity, its derivative and their preparation

Publications (2)

Publication Number Publication Date
ATA224578A true ATA224578A (de) 1980-09-15
AT362059B AT362059B (de) 1981-04-27

Family

ID=26374352

Family Applications (1)

Application Number Title Priority Date Filing Date
AT224578A AT362059B (de) 1977-03-31 1978-03-30 Verfahren zur herstellung eines neuen antibiotikums und seiner derivate

Country Status (21)

Country Link
US (1) US4318916A (de)
AR (1) AR219738A1 (de)
AT (1) AT362059B (de)
AU (1) AU518781B2 (de)
CA (1) CA1123767A (de)
CH (1) CH643262A5 (de)
DE (1) DE2813922A1 (de)
DK (1) DK144098C (de)
FI (1) FI59813C (de)
FR (1) FR2408608B1 (de)
GB (1) GB1598062A (de)
GR (1) GR62185B (de)
IE (1) IE46369B1 (de)
IL (1) IL54118A (de)
IT (1) IT1113066B (de)
LU (1) LU79351A1 (de)
NL (1) NL7802976A (de)
NO (1) NO781076L (de)
NZ (1) NZ186830A (de)
PT (1) PT67848B (de)
SE (1) SE7803623L (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0011173B1 (de) 1978-11-01 1983-05-11 Sanraku-Ocean Co., Ltd. Verfahren zur Herstellung von antibiotischen Beta-Lactam-Verbindungen
DE3146190A1 (de) * 1981-11-21 1983-06-16 Hoechst Ag, 6230 Frankfurt Isolierung von chemisch instabilen antibiotika aus fermentationsloesungen
US5650290A (en) * 1994-04-01 1997-07-22 Hach Company Method & Medium for use in detecting E. coli and total coliforms
US5849515A (en) * 1994-04-01 1998-12-15 Hach Company Method and medium for use in detecting E. coli and total coliforms
KR100379075B1 (en) * 2002-03-07 2003-04-08 Jinis Biopharmaceuticals Co Method for producing low cholesterol animal food product and food product therefrom
FI20205368A1 (en) * 2020-04-07 2021-10-08 Aalto Univ Foundation Sr FORMULATION
CN111826334A (zh) * 2020-07-24 2020-10-27 暨南大学 一种超长大肠杆菌及其制备方法与应用
CN113960188B (zh) * 2021-09-09 2024-01-26 中车青岛四方机车车辆股份有限公司 高效液相色谱-串联质谱法测定样品中的4,4-二(二甲氨基)-4-甲氨基三苯甲醇

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3928569A (en) * 1972-08-09 1975-12-23 Microbial Chem Res Found Two substances inhibiting beta-lactamase and their production
GB1467413A (en) * 1974-03-28 1977-03-16 Beecham Group Ltd Antibiotics
US3950357A (en) * 1974-11-25 1976-04-13 Merck & Co., Inc. Antibiotics
US4165379A (en) * 1975-11-21 1979-08-21 Merck & Co., Inc. N-acetyl thienamycin
US4162324A (en) * 1975-11-21 1979-07-24 Merck & Co., Inc. Antibiotics 890A1 and 890A3
NL7704040A (nl) * 1976-04-28 1977-11-01 Merck & Co Inc Werkwijze voor het bereiden van nieuwe anti- biotica.
NL7802826A (nl) * 1977-04-08 1978-10-10 Merck & Co Inc Thienamycinederivaat, werkwijze voor het bereiden daarvan, alsmede farmaceutische preparaten.
US4162323A (en) * 1977-04-18 1979-07-24 Merck & Co., Inc. Antibiotic N-acetyl-dehydro-thienamycin
US4235922A (en) * 1979-06-15 1980-11-25 Merck & Co., Inc. 3-(2-Aminoethylthio)-6-ethyl-7-oxo-1-azabicyclo [3.2.0]hept-2-ene-2-carboxylic acid

Also Published As

Publication number Publication date
IE46369B1 (en) 1983-05-18
US4318916A (en) 1982-03-09
FR2408608A1 (fr) 1979-06-08
IT7821748A0 (it) 1978-03-30
IE780638L (en) 1978-09-30
GR62185B (en) 1979-03-02
IT1113066B (it) 1986-01-20
SE7803623L (sv) 1978-11-17
DE2813922A1 (de) 1978-10-19
PT67848A (en) 1978-04-01
AU518781B2 (en) 1981-10-22
NL7802976A (nl) 1978-10-03
DK144098C (da) 1982-06-01
DK144098B (da) 1981-12-07
AR219738A1 (es) 1980-09-15
DK143678A (da) 1978-10-01
FI780671A (fi) 1978-10-01
NO781076L (no) 1978-10-03
IL54118A (en) 1981-09-13
LU79351A1 (fr) 1979-03-26
FI59813B (fi) 1981-06-30
PT67848B (en) 1979-09-28
FI59813C (fi) 1981-10-12
AU3459278A (en) 1979-10-04
GB1598062A (en) 1981-09-16
AT362059B (de) 1981-04-27
CA1123767A (en) 1982-05-18
NZ186830A (en) 1981-12-15
FR2408608B1 (fr) 1986-05-16
CH643262A5 (de) 1984-05-30

Similar Documents

Publication Publication Date Title
AT361142B (de) Verfahren zur herstellung eines neuen tetra- decapeptids und seiner saeureadditionssalze
AT364851B (de) Verfahren zur herstellung von neuen thienothiazinderivaten und von deren salzen
AT371454B (de) Verfahren zur herstellung von neuen prostanderivaten und von deren salzen
AT366043B (de) Verfahren zur herstellung von neuen chinazolinderivaten und deren salzen
AT370130B (de) Verfahren zur herstellung eines neuen glycopeptid-antibiotikums und seiner saeureadditionssalze
AT362064B (de) Verfahren zur herstellung des neuen 4-spectino- mycylamins und seiner physiologisch ver- traeglichen salze
AT359643B (de) Verfahren zur herstellung von neuen 4"-ery- thromycin-a-derivaten
AT362059B (de) Verfahren zur herstellung eines neuen antibiotikums und seiner derivate
AT342768B (de) Verfahren zur herstellung eines neuen antibiotikums
AT363937B (de) Verfahren zur herstellung von neuen bispidinderivaten und deren salzen
AT371112B (de) Verfahren zur herstellung von neuen 2-imino-imidazolidin-derivaten und von deren salzen
ATA747378A (de) Verfahren zur herstellung von neuen 1-aryl-alkyl-imidazolderivaten und deren salzen
AT377004B (de) Verfahren zur herstellung eines neuen komplexes eines polyaether-antibiotikums
AT346479B (de) Verfahren zur herstellung eines neuen antibioticum-gemisches und seiner komponenten
AT356295B (de) Verfahren zur herstellung eines neuen morphanderivates
AT362060B (de) Verfahren zur herstellung von neuen anti- biotika (a-40104)und derivaten davon
AT365183B (de) Verfahren zur herstellung von neuen 4-amino-2-piperidinochinazolinderivaten und deren salzen
AT366742B (de) Verfahren zur herstellung eines bauelementes und bauelement
ATA73877A (de) Verfahren zur herstellung von neuen oxadiazolopyrimidinderivaten und von deren salzen
ATA503878A (de) Verfahren zur herstellung von neuen acyl- derivaten des antibiotikums bm123gamma
AT357670B (de) Verfahren zur herstellung eines neuen anti- biotikums
AT362061B (de) Verfahren zur herstellung eines neuen antibiotikums
ATA356778A (de) Verfahren zur herstellung von neuen 4-hydroxy- thiazolidin-2-thion-derivaten und von deren salzen
AT362506B (de) Verfahren zur herstellung von neuen ester- derivaten eines antibiotikums
ATA418082A (de) Verfahren zur herstellung eines neuen macrolid-antibiotikums

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee